Ocular complications of vincristine therapy.
D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D001763:Blepharoptosis / Q000139:chemically induced*; D002455:Cell Division / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005128:Eye Diseases / Q000139:chemically induced*; D005158:Facial Paralysis / Q000139:chemically induced; D005260:Female; D005684:Gait; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced; D009461:Neurologic Manifestations; D009886:Ophthalmoplegia / Q000139:chemically induced*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D051381:Rats; D012026:Reflex, Stretch; D014276:Trigeminal Nerve; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D014750:Vincristine